Yalkinoglu, Özkan
Becker, Andreas
Krebs-Brown, Axel
Vetter, Claudia
Lüpfert, Christian
Perrin, Dominique
Heuer, Jürgen
Biedert, Herlind
Hirt, Stefan
Bytyqi, Afrim
Bachmann, Angelika
Strotmann, Rainer
Funding for this research was provided by:
the healthcare business of Merck KGaA, Darmstadt, Germany
Article History
Received: 8 June 2023
Accepted: 21 June 2023
First Online: 6 July 2023
Declarations
:
: Both clinical studies were conducted in accordance with the principles of the Declaration of Helsinki and the International Council on Harmonisation Good Clinical Practice guidelines. Both studies were conducted in Germany, and were approved by Ethik-Kommission der Bayerischen Landesärztekammer (Ethics Committee, Bavarian Chamber of Physicians).
: Written informed consent was obtained from all participants before any study-related procedures were performed.
: Özkan Yalkinoglu, Andreas Becker, Claudia Vetter, Christian Lüpfert, Afrim Bytyqi, Rainer Strotmann, Axel Krebs-Brown, Angelika Bachmann and Dominique Perrin are (or were at the time of the studies) employees of the healthcare business of Merck KGaA, Darmstadt, Germany. Jürgen Heuer, Herlind Biedert and Stefan Hirt are employees of Nuvisan, Germany, who were contracted by the healthcare business Merck KGaA, Darmstadt, Germany, for support with the studies reported here.